Health Canada drug identification number

DIN 02446944 — ENTRESTO 103 MG; 97 MG

ENTRESTO is a tablet of Sacubitril / Valsartan marketed by NOVARTIS PHARMACEUTICALS CANADA INC. The full Sacubitril / Valsartan monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02446944
Brand name
ENTRESTO
Active ingredient
Sacubitril / Valsartan
Strength
103 MG; 97 MG
Dosage form
TABLET
Route
ORAL
Manufacturer
NOVARTIS PHARMACEUTICALS CANADA INC
Health Canada status
MARKETED
Drug class
Angiotensin receptor-neprilysin inhibitor (ARNI)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Sacubitril / Valsartan products

DINBrandStrengthFormManufacturerStatus
02446928 ENTRESTO 26 MG; 24 MG TABLET NOVARTIS PHARMACEUTICALS CANADA INC MARKETED
02446936 ENTRESTO 49 MG; 51 MG TABLET NOVARTIS PHARMACEUTICALS CANADA INC MARKETED
02564432 PMS-SACUBITRIL-VALSARTAN 26 MG; 24 MG TABLET PHARMASCIENCE INC MARKETED
02564440 PMS-SACUBITRIL-VALSARTAN 51 MG; 49 MG TABLET PHARMASCIENCE INC MARKETED
02564459 PMS-SACUBITRIL-VALSARTAN 97 MG; 103 MG TABLET PHARMASCIENCE INC MARKETED
02549034 SANDOZ SACUBITRIL-VALSARTAN 103 MG; 97 MG TABLET SANDOZ CANADA INCORPORATED MARKETED
02549018 SANDOZ SACUBITRIL-VALSARTAN 24 MG; 26 MG TABLET SANDOZ CANADA INCORPORATED MARKETED
02549026 SANDOZ SACUBITRIL-VALSARTAN 51 MG; 49 MG TABLET SANDOZ CANADA INCORPORATED MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.